{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T04:36:31Z","timestamp":1730349391096,"version":"3.28.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.clinthera.2024.08.001","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T13:46:37Z","timestamp":1725630397000},"page":"812-818","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of Pain in Cirrhosis: Advice to Caregivers of Those with Rock Livers"],"prefix":"10.1016","volume":"46","author":[{"given":"Randolph E.","family":"Regal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2024.08.001_bib0001","unstructured":"Reduce Cirrhosis Deaths \u2013 su\u201102 Data. Reduce Cirrhosis Deaths \u2013 Data \u2013 Healthy People 2030. n.d. https:\/\/health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/drug-and-alcohol-use\/reduce-cirrhosis-deaths-su-02\/data."},{"key":"10.1016\/j.clinthera.2024.08.001_sbref0002","series-title":"Pathophysiology of Disease: An Introduction to Clinical Medicine, 8e","article-title":"Liver disease","author":"Mukhtar","year":"2019"},{"issue":"1","key":"10.1016\/j.clinthera.2024.08.001_bib0003","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/0269216318807051","article-title":"Symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis","volume":"33","author":"Peng","year":"2019","journal-title":"Palliat Med"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.clinthera.2024.08.001_bib0006","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/cts.13428","article-title":"Design and conduct considerations for studies in patients with hepatic impairment","volume":"16","author":"Ravenstijn","year":"2023","journal-title":"Clin Transl Sci"},{"issue":"3","key":"10.1016\/j.clinthera.2024.08.001_bib0007","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40266-015-0242-4","article-title":"National indicators for quality of drug therapy in older persons:the swedish experience from the first 10 years","volume":"32","author":"Fastbom","year":"2015","journal-title":"Drugs Aging"},{"issue":"2 Suppl","key":"10.1016\/j.clinthera.2024.08.001_bib0008","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.pmn.2010.03.003","article-title":"Balancing analgesic efficacy with safety concerns in the older patient","volume":"11","author":"Arnstein","year":"2010","journal-title":"Pain Manag Nurs"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0009","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2165\/00002018-200932060-00003","article-title":"Treatment of chronic non-malignant pain in the elderly: safety considerations","volume":"32","author":"Barber","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0004","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4254\/wjh.v9.i3.131","article-title":"Cockcroft-gault revisited: new de-liver-ance on recommendations for use in cirrhosis","volume":"9","author":"Scappaticci","year":"2017","journal-title":"W J Hepatol"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1383\/medc.30.11.24.28446","article-title":"Pharmacokinetics and pharmacodynamics in cirrhosis","volume":"30","author":"Kr\u00e4henb\u00fchl","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0011","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1389200043489054","article-title":"The effect of liver cirrhosis on the regulation and expression of drug metabolizing enzymes","volume":"5","author":"Elbekai","year":"2005","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0012","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2165\/00002018-200528060-00005","article-title":"Dose adjustment in patients with liver disease","volume":"28","author":"Delc\u00f2","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6170243","article-title":"A comprehensive review of portosystemic collaterals in cirrhosis: historical aspects, anatomy, and classifications","volume":"2016","author":"Philips","year":"2016","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0014","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-008-0553-z","article-title":"Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction","volume":"64","author":"Verbeeck","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/11318160-000000000-00000","article-title":"A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance","volume":"49","author":"Johnson","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0016","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/0016-5085(95)90695-9","article-title":"Localization of uridine 5-diphosphate-glucurononosyltransferease in human liver injury","volume":"108","author":"Debinski","year":"1995","journal-title":"Gastroenterol"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0017","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2478\/v10153-011-0100-z","article-title":"Pathogenesis and assessment of renal function in patients with liver cirrhosis","volume":"54","author":"Teneva","year":"2012","journal-title":"Folia Med (Plovdiv)"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0018","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1001\/archinte.1988.00380060077017","article-title":"Low serum creatinine levels in severe hepatic disease","volume":"148","author":"Takabatake","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0019","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/ndt\/gfi305","article-title":"Calculation of glomerular filtration rate based on Cystatin C in cirrhotic patients","volume":"21","author":"P\u00f6ge","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archinte.1994.00420020117013","article-title":"Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis","volume":"154","author":"Caregaro","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0022","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/0091270009336234","article-title":"Systemic bioavailability of topical diclofenac gel 1% versus oral diclofenac sodium in healthy volunteers","volume":"50","author":"Kienzler","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0023","unstructured":"Acetaminophen (Package Insert). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/204767s000lbl.pdf."},{"key":"10.1016\/j.clinthera.2024.08.001_bib0024","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2036.2004.02022.x","article-title":"Pharmacokinetic variations of acetaminophen according to liver dysfunction and portal hypertension status","volume":"20","author":"Zapater","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0025","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4065\/mcp.2009.0534","article-title":"Pain management in the cirrhotic patient: the clinical challenge","volume":"85","author":"Chandok","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0026","unstructured":"Ultram (tramadol hydrochloride) tablets (package insert). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/020281s032s033lbl.pdf."},{"key":"10.1016\/j.clinthera.2024.08.001_bib0027","first-page":"99","article-title":"Pharmacokinetics of tramadol in patients with liver cancer","volume":"4","author":"Kotb","year":"2008","journal-title":"J Opiod Manag"},{"issue":"6","key":"10.1016\/j.clinthera.2024.08.001_bib0028","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/cld.711","article-title":"Pain Management in patients with cirrhosis","volume":"11","author":"Rakoski","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0029","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2165\/11635500-000000000-00000","article-title":"Analgesics in patients with hepatic impairment: pharmacology and clinical implications","volume":"72","author":"Bosilkovska","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0030","article-title":"Tramadol dependence in a patient with no previous substance history","volume":"12","author":"Ojha","year":"2010","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0031","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00003088-199937010-00002","article-title":"Pharmacokinetics of opioids in liver disease","volume":"37","author":"Tegeder","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0032","unstructured":"Morphine Sulfate Tablets Full Prescribing Information (package insert). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/022207s004lbl.pdf."},{"key":"10.1016\/j.clinthera.2024.08.001_bib0033","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2125.1990.tb03638.x","article-title":"The metabolism and bioavailability of morphine in patients with severe liver cirrhosis","volume":"29","author":"Hasselstrom","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0034","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/bja\/79.6.804","article-title":"Pharmacokinetics of contrlloed release morphine (MST) in patients with liver cirrhosis","volume":"79","author":"Kotb","year":"1997","journal-title":"Br J Anesth"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0035","unstructured":"Oxycontin (Oxycodone HCL Controlled-Release) Tablets (package insert). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/020553s060lbl.pdf."},{"key":"10.1016\/j.clinthera.2024.08.001_bib0036","unstructured":"Roxybond (oxycodone) [package insert]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/209777s001s003lbl.pdf."},{"key":"10.1016\/j.clinthera.2024.08.001_bib0037","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0009-9236(96)90024-7","article-title":"Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone","volume":"59","author":"Kaiko","year":"1996","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.clinthera.2024.08.001_bib0038","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","article-title":"Opioid metabolism","volume":"84","author":"Smith","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0040","unstructured":"Dilaudid and dlaudid-hp Injection 1 mg\/ML, 2 mg\/ML, 4MG\/ml, and 10 mg (package insert). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/019034s018lbl.pdf."},{"key":"10.1016\/j.clinthera.2024.08.001_bib0041","unstructured":"Medication Guide Duragesic (package insert). https:\/\/www.janssenlabels.com\/package-insert\/product-patient-information\/DURAGESIC-medication-guide.pdf."},{"issue":"4","key":"10.1016\/j.clinthera.2024.08.001_bib0042","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1530-0277.1985.tb05558.x","article-title":"Effect of severe alcoholic ilver disease on the disposition of methadone in maintenance patients","volume":"9","author":"Novick","year":"1985","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0043","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/clpt.1981.172","article-title":"Methadone disposition in patients with chronic liver disease","volume":"30","author":"Novick","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0044","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/0976-0105.168053","article-title":"A rare case of bilateral lower extremity edema due to low dose gabapentin therapy in a young male patient","volume":"6","author":"Kahlon","year":"2015","journal-title":"J Basic Clin Pharm"},{"year":"2021","series-title":"Capsules (Product Monograph)","author":"Cymbalta Duloxetine","key":"10.1016\/j.clinthera.2024.08.001_bib0045"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0046","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12876-015-0373-4","article-title":"Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database","volume":"15","author":"Lin","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0047","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4306\/pi.2011.8.3.269","article-title":"Duloxetine-induced liver injury in patients with major depressive disorder","volume":"8","author":"Kang","year":"2011","journal-title":"Psychiatry Invest"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0048","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5414\/CPP43078","article-title":"Duloxetine pharmacokinetics in cirrhotics compared with healthy subjects","volume":"43","author":"Suri","year":"2005","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0050","series-title":"Medical Genetics Summaries","article-title":"Venlafaxine therapy and CYP2D6 genotype. 2015 Jul 27 [Updated 2020 Jun 29]","author":"Dean","year":"2012"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0051","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/apt.12324","article-title":"Review article: prescribing medications in patients with cirrhosis \u2013 a practical guide","volume":"37","author":"Lewis","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.clinthera.2024.08.001_bib0053","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s40262-014-0187-5","article-title":"Pharmacokinetics of antidepressants in patients with hepatic impairment","volume":"53","author":"Mauri","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0054","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/apt.12925","article-title":"Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation","volume":"40","author":"Mullish","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2024.08.001_bib0055","first-page":"149","article-title":"Chemistry, metabolism, and toxicology of cannabis: clinical implications","volume":"7","author":"Sharma","year":"2012","journal-title":"Iranian J Psychiatry"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291824002121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291824002121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T02:50:47Z","timestamp":1730343047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291824002121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0149291824002121"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2024.08.001","relation":{},"ISSN":["0149-2918"],"issn-type":[{"type":"print","value":"0149-2918"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Pain in Cirrhosis: Advice to Caregivers of Those with Rock Livers","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2024.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}